Description
BSE announces the listing and admission of equity shares of Nephrocare Health Services Limited for trading on the exchange with scrip code 544647 and symbol NEPHROPLUS.
Summary
BSE has announced that equity shares of Nephrocare Health Services Limited will be listed and admitted to trading on the exchange. The company has been assigned scrip code 544647 and trading symbol NEPHROPLUS with ISIN number INE428V01029. The exact listing date and detailed security information will be communicated through a separate notice.
Key Points
- Company Name: Nephrocare Health Services Limited
- Scrip Code: 544647
- Trading Symbol: NEPHROPLUS
- ISIN Number: INE428V01029
- Listing status: To be listed in due course
- Specific listing date to be announced separately
Regulatory Changes
No regulatory changes introduced. This is a standard new listing notification.
Compliance Requirements
Trading members of BSE are informed to note the new listing and prepare systems for trading once the listing date is announced.
Important Dates
- Notice Date: December 16, 2025
- Listing Date: To be announced through separate notice
Impact Assessment
This listing adds a new equity security to the BSE platform in the healthcare services sector. Trading members should update their systems and be prepared to facilitate trading once the listing becomes effective. The announcement provides advance notice to allow market participants to prepare for the new listing.
Impact Justification
New stock listing announcement with medium impact for market participants. Specific listing date to be announced separately.